Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

143

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-26

HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days ago

HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin

Treble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days ago

Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Compagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks ago

Compagnie Financière et de Participations Roullier2 weeks ago

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin

Biotech UK

162 companies matching · Page 1 of 4

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Akamis Bio3 periods IP Group (Evergreen)	Biotech	UK	IP Group	2012	14yr	Active	–	–
Dark Blue Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2020	6yr	Exited 2026	Amgen	–
Chain Biotechnology UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2017	9yr	Exited 2026	–	–
Cube3 periods Hg Mercury 4	Biotech	UK	Hg	2021	5yr	Active	–	–
Cytox Group UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	–	–	Exited 2024	–	–
PetMedix2 periods CIC Fund II	Biotech	UK	Cambridge Innovation Capital	2019	4yr	Exited 2023	Zoetis	–
Zihpp IP Group (Evergreen)	Biotech	UK	IP Group	2019	4yr	Exited 2023	Metsera	–
DJS Antibodies2 periods LifeArc Ventures	Biotech	UK	LifeArc	2016	6yr	Exited 2022	AbbVie	–
Ducentis BioTherapeutics LifeArc Ventures	Biotech	UK	LifeArc	2019	3yr	Exited 2022	Arcutis Biotherapeutics	–
MiroBio Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2019	3yr	Exited 2022	Gilead Sciences	–
Gyroscope Therapeutics CIC Fund I	Biotech	UK	Cambridge Innovation Capital	2019	2yr	Exited 2021	Novartis	–
BioAgilytix4 periods Cinven Seventh Fund	Biotech	UK	Cinven	2018	8yr	Active	–	–
Oxford Nanopore Technologies3 periods Novo Holdings Growth Investments	Biotech	UK	Novo Holdings	2005	16yr	Active	–	–
BioCity Group BGF	Biotech	UK	BGF	2019	2yr	Exited 2021	Trinity Investment Management and Harrison Street	–
OXGENE Mercia Direct Investments	Biotech	UK	Mercia Asset Management	2015	6yr	Exited 2021	WuXi AppTec	5.0x
Vaccitech Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2016	5yr	Exited 2021	–	–
The Native Antigen Company Mercia Direct Investments	Biotech	UK	Mercia Asset Management	2014	6yr	Exited 2020	LGC	8.4x
Base Genomics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2018	2yr	Exited 2020	Exact Sciences	–
Bicycle Therapeutics CIC Fund I	Biotech	UK	Cambridge Innovation Capital	2016	3yr	Exited 2019	–	–
Orchard Therapeutics 4BIO Ventures III	Biotech	UK	4Bio Partners	2017	1yr	Exited 2018	–	–
Quethera UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2015	3yr	Exited 2018	Astellas Pharma	–
Fusion Antibodies Plc QUBIS Ltd	Biotech	UK	Qubis	2002	15yr	Exited 2017	–	–
Horizon Discovery Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2013	4yr	Exited 2017	–	–
Cytospire Therapeutics3 periods Abingworth Bioventures 8	Biotech	UK	Abingworth	2023	3yr	Active	–	–
Dia Beta Labs3 periods Co-Fund NI III	Biotech	UK	Clarendon Fund Managers	2022	4yr	Active	–	–
Healx3 periods Atomico IV	Biotech	UK	Atomico	2018	8yr	Active	–	–
Nuclera3 periods CIC Fund II	Biotech	UK	Cambridge Innovation Capital	2022	4yr	Active	–	–
StimOxyGen3 periods QUBIS Ltd	Biotech	UK	Qubis	2025	1yr	Active	–	–
Trogenix3 periods Old College Capital LP	Biotech	UK	Old College Capital	2023	3yr	Active	–	–
Wobble Genomics3 periods BGF	Biotech	UK	BGF	2021	5yr	Active	–	–
Aerska2 periods BlueYard Capital Fund III	Biotech	UK	BlueYard Capital	2025	1yr	Active	–	–
Alveogene2 periods Old College Capital LP	Biotech	UK	Old College Capital	2023	3yr	Active	–	–
Antiverse2 periods Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2020	6yr	Active	–	–
Atelerix2 periods Angel CoFund	Biotech	UK	ACF Investors	2018	8yr	Active	–	–
AviadoBio2 periods Dementia Discovery Fund	Biotech	UK	SV Health Managers	2020	6yr	Active	–	–
Carrick Therapeutics2 periods Rosetta Capital V	Biotech	UK	Rosetta Capital	2016	10yr	Active	–	–
CellCentric2 periods Sofinnova Crossover Fund I	Biotech	UK	Sofinnova Partners	2026	0yr	Active	–	–
Istesso2 periods Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2017	9yr	Active	–	–
NanoSyrinx2 periods BGF	Biotech	UK	BGF	2021	5yr	Active	–	–
Pencil Biosciences2 periods Northern Gritstone Evergreen	Biotech	UK	Northern Gritstone	2023	3yr	Active	–	–
TRIMTECH Therapeutics2 periods CIC Fund II	Biotech	UK	Cambridge Innovation Capital	2023	3yr	Active	–	–
Alchemab Therapeutics SV7 Impact Medicine Fund	Biotech	UK	SV Health Managers	2019	7yr	Active	–	–
Amphista Therapeutics Dementia Discovery Fund	Biotech	UK	SV Health Managers	2022	4yr	Active	–	–
Amply Discovery Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	5yr	Active	–	–
AMR Bio EMV Capital Evergreen Fund	Biotech	UK	EMV Capital	2025	1yr	Active	–	–
Aramune Technologies Co-Fund NI	Biotech	UK	Clarendon Fund Managers	2022	4yr	Active	–	–
Aramune Technologies Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	5yr	Active	–	–
Arctoris Future Planet Fund I	Biotech	UK	Future Planet Capital	2019	7yr	Active	–	–
ArkVax UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2022	4yr	Active	–	–
Ascend Advanced Therapies 4BIO Ventures III	Biotech	UK	4Bio Partners	2023	3yr	Active	–	–

Portfolio companies.21,000+ PE-backed.

Portfolio companies.
21,000+ PE-backed.